An apparatus for the separation and purification of bioactive peptides
By separating the permeate chamber into independent filtration zones in the bioactive peptide membrane separation device and using reverse flow and electric field control to achieve local membrane recovery, the problem of local contamination affecting the overall separation process is solved, thus improving the stability and efficiency of separation and purification.
Patent Information
- Application Number
- CN202611218291.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-08-12
- Publication Date
- 2026-11-17
AI Technical Summary
Existing membrane modules used for continuous membrane separation of bioactive peptides require the entire membrane module to be stopped for recovery treatment when local fouling occurs. This makes it difficult to balance local membrane recovery and continuous filtration, affecting the continuity of the separation and purification process and the efficiency of membrane area utilization.
The separation and purification device includes a membrane separation component, a permeate outlet component, a local recovery component, and an electric field control component. The permeate chamber is divided to form independent filtration zones, and the permeate output and electric field state are controlled separately. Local membrane recovery is achieved through reverse flow and electric field control.
This technology enables independent control of the recovery and maintenance of each filtration zone based on continuous tangential flow of the feed liquid, thereby improving the utilization efficiency of the membrane module and the stability of the separation and purification process, and reducing the impact of local contamination on the overall process.
Smart Images

Figure CN123102149A_ABST
Abstract
Description
Technical Field
[0001] This application relates to the field of bioactive peptide separation and purification and membrane separation equipment technology, and specifically discloses a device for separating and purifying bioactive peptides. Background Technology
[0002] Bioactive peptides are typically obtained from proteins through enzymatic hydrolysis, fermentation, or other degradation treatments. The resulting feed solution, in addition to the target peptide, also contains incompletely hydrolyzed proteins, large polypeptides, small peptides, free amino acids, inorganic salts, and other soluble components. Therefore, after obtaining the protein hydrolysate, further fractionation, concentration, and purification are usually required. Membrane separation offers advantages such as mild processing conditions, ease of continuous operation, and suitability for maintaining peptide activity. Tangential flow membrane separation, in particular, allows the feed solution to flow along the membrane surface and utilizes transmembrane pressure to allow components meeting separation conditions to permeate through the membrane, thus mitigating the direct accumulation of solids on the membrane surface. For charged peptide components, an electric field can be superimposed during membrane separation to alter the migration state of different peptide components.
[0003] In existing continuous tangential flow separation devices, the feed concentration, transmembrane pressure, and local flow conditions are not entirely consistent at different locations as the feed solution flows along the membrane module. The rates at which proteins, macropeptides, and easily adsorbed components form concentration polarization, adsorption layers, or fouling layers also vary in different membrane zones, resulting in significant localized membrane fouling. Currently, the permeate side of existing membrane modules is typically collected uniformly, and backwashing or cleaning circuits and electric field application areas are often controlled uniformly for the entire membrane module. When a localized membrane zone experiences a flux decline and requires recovery treatment, while the remaining membrane zones still have normal filtration capacity, it is still necessary to stop product collection for the entire membrane module and implement overall backwashing, cleaning, or a uniform change in the electric field state. This causes the normal membrane zones to simultaneously exit the filtration process, making it difficult to implement targeted recovery of fouled membrane zones while maintaining continuous tangential flow of the feed solution. Consequently, this affects the operational continuity of the continuous separation and purification process of bioactive peptides and the membrane area utilization efficiency.
[0004] Therefore, in view of this, the present invention provides an apparatus for the separation and purification of bioactive peptides in order to solve the above-mentioned problems. Summary of the Invention
[0005] The purpose of this invention is to solve the problem that when local fouling occurs in existing membrane modules used for continuous membrane separation of bioactive peptides, it is usually necessary to stop product collection of the entire membrane module and carry out unified recovery treatment, which makes it difficult to simultaneously achieve local membrane recovery and continuous filtration.
[0006] To achieve the above objectives, the basic solution of the present invention provides a device for separating and purifying bioactive peptides, including a membrane separation component, a permeate outlet component, a local recovery component, and an electric field control component. The membrane separation component has a continuous tangential feed channel and a separation membrane disposed on one side thereof. The permeate side of the separation membrane is divided into at least two independent permeate chambers along the feed flow direction, and each permeate chamber is respectively formed as a filtration zone.
[0007] The permeate discharge assembly is used to control the permeate output of each of the permeate chambers respectively;
[0008] The local recovery component is used to selectively generate a reverse flow of liquid from the permeation side to the feed liquid side in any of the filter zones;
[0009] Each of the filter zones is provided with an independently adjustable electric field control unit so that when one filter zone undergoes partial recovery, at least one of the remaining filter zones maintains the filtering state.
[0010] Furthermore, the membrane separation assembly includes a housing, which has a feed inlet and a feed outlet, and the continuous tangential flow feed channel extends from the feed inlet to the feed outlet;
[0011] The permeation side of the separation membrane is provided with a partition structure, which forms a liquid-tight connection with the separation membrane and the housing, so that adjacent permeation liquid chambers are not directly connected to each other, and the feed liquid side of each filtration zone is connected to the continuous tangential flow feed liquid channel.
[0012] Furthermore, the permeate discharge assembly includes a permeate branch that is connected to each of the permeate chambers and a product manifold that is connected to each of the permeate branches. Each of the permeate branches is provided with a product control valve to independently control the connection state between the corresponding permeate chamber and the product manifold.
[0013] Furthermore, the local recovery assembly includes a reverse pulse reservoir, a pulse generator, a backflush main pipe, and reverse pulse branches respectively connected to each of the permeable liquid chambers. The reverse pulse reservoir is connected to the backflush main pipe through the pulse generator, and each of the reverse pulse branches is provided with a backflush control valve.
[0014] The pulse generator is used to apply a reverse pressure pulse to a selected permeate chamber, causing the reverse pulse medium to pass through the separation membrane of the corresponding filtration zone and enter the continuous tangential flow liquid channel.
[0015] Furthermore, each of the electric field control units includes a first electrode and a second electrode located on both sides of the corresponding filtration zone, and ion exchange membranes are respectively provided between the first electrode and the continuous tangential flow liquid channel and between the second electrode and the corresponding permeation side.
[0016] The electric field control units corresponding to different filter zones are connected to the electric field driver to independently perform at least one of the following: electric field opening, closing, field intensity adjustment, polarity change, pulse adjustment, or alternating adjustment.
[0017] Furthermore, it also includes a detection component and a control component, wherein the detection component is used to acquire at least one of the permeate flow rate and permeate side pressure in each of the filtration zones;
[0018] The control component is used to determine the filtration status of each filtration zone according to the filtration status parameters, and to control the permeate output, reverse flow and electric field operation status of the corresponding filtration zone, so that the filtration zone that has reached the preset recovery condition can perform local recovery.
[0019] Furthermore, it also includes a conditioning tank for containing bioactive peptide solution and a circulation pump for driving the solution into the continuous tangential flow solution channel, wherein the conditioning tank is equipped with a temperature control component and a pH control component.
[0020] The feed outlet of the membrane separation unit is connected to the conditioning tank via a retentate circulation pipe, so that the feed that has not passed through the separation membrane is returned to the conditioning tank for recycling.
[0021] Furthermore, the permeate output path of at least one of the filter zones is also connected to the transition liquid guide branch, so that when a filter zone is partially restored, the permeate generated by at least one filter zone downstream of that filter zone can temporarily leave the product collection flow path.
[0022] And / or, the membrane separation assembly is configured as two or more, and each membrane separation assembly is connected in series, parallel or series-parallel, and at least two of the membrane separation assemblies use separation membranes with different retention characteristics.
[0023] Based on the same inventive concept, the present invention also provides a method for separating and purifying bioactive peptides, wherein the bioactive peptide feed solution flows continuously tangentially along the feed solution side of the separation membrane, and the permeate of the corresponding filtration zone is collected by at least two independent permeate chambers disposed on the permeate side of the separation membrane.
[0024] The filtration state of each filtration zone is determined. When a filtration zone reaches the recovery condition, the product output of that filtration zone is stopped, a reverse liquid flow is applied from its permeation side to the liquid side, and the electric field state corresponding to that filtration zone is changed, while at least one other filtration zone is kept filtering.
[0025] After the recovery is complete, the filtration area will resume product output.
[0026] Furthermore, the filtration zone is determined to have reached the recovery condition based on at least one of the following: permeate flow rate, permeate flux, transmembrane pressure, permeate flow rate decrease rate, permeate flux decrease degree, transmembrane pressure change rate, and permeate capacity corresponding to unit transmembrane pressure.
[0027] During the local recovery process, one or more reverse pressure pulses are applied to the filter zone that has reached the recovery condition, and the electric field corresponding to the filter zone is subjected to at least one of the following: shutdown, field strength change, polarity change, alternating change, or pulse change.
[0028] When there is a filtration zone that maintains filtration status downstream of the filtration zone undergoing partial restoration, the permeate generated by at least one of the downstream filtration zones is temporarily introduced into the transition liquid return path or the transition liquid collection path, and the product output of the downstream filtration zone is restored after the partial restoration is completed and the liquid status is stable.
[0029] The principle and effect of this basic scheme are as follows:
[0030] 1. The present invention divides the permeate side of the separation membrane into at least two independent permeate chambers while maintaining continuous tangential flow on the feed side, so that each permeate chamber forms an independently controllable filtration zone, thereby providing a structural basis for independent liquid discharge, state judgment and local control of different membrane zones.
[0031] 2. When one of the filtration zones reaches the recovery condition, the product output of that filtration zone can be stopped, and a reverse liquid flow can be applied from its permeate side to the feed liquid side, so that the recovery effect is concentrated on the local membrane area where the fouling has occurred, without the need to backflushing or cleaning the entire membrane module, thus improving the targeted nature of membrane recovery.
[0032] 3. During the local membrane recovery process, at least one of the remaining filtration zones can still maintain normal tangential flow filtration, and the feed liquid side maintains continuous flow, so that the pollutants detached from the membrane zone to be recovered can be carried away by the tangential flow in a timely manner, thereby reducing the impact of local membrane fouling on the continuity of the entire separation process.
[0033] 4. Each filtration zone is equipped with an independently adjustable electric field control unit, which allows the filtration zone to be restored to change its electric field state independently and act together with the reverse liquid flow on the same local membrane zone, while the other filtration zones maintain their normal separation electric field state. This is conducive to achieving synergy between zoned electric field control and local membrane restoration.
[0034] 5. By acquiring the permeate flow rate, permeate flux, and / or pressure status of each filtration zone, local recovery can be selectively initiated according to the actual operating status of different membrane zones. Furthermore, the impact of the recovery process on downstream product collection can be reduced by combining the transition liquid diversion method, thereby improving the effective utilization of the membrane module and the operational stability of the continuous separation and purification process of bioactive peptides. Attached Figure Description
[0035] To more clearly illustrate the technical solutions in the embodiments of this application, the accompanying drawings used in the description of the embodiments will be briefly introduced below. Obviously, the accompanying drawings described below are only some embodiments of this application. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.
[0036] Figure 1 A schematic diagram of the system structure of a bioactive peptide separation and purification device proposed in an embodiment of this application is shown.
[0037] Figure 2 This paper shows a cross-sectional view of the partitioned electric field-assisted tangential flow membrane filter proposed in an embodiment of this application.
[0038] Figure 3 This illustration shows a schematic diagram of a multi-stage separation system formed by connecting multiple partitioned electric field-assisted tangential flow membrane filters in series, as proposed in an embodiment of this application. Detailed Implementation
[0039] To further illustrate the technical means and effects of the present invention in achieving its intended purpose, the following detailed description of the specific implementation methods, structures, features, and effects of the present invention, in conjunction with the accompanying drawings and preferred embodiments, is provided below.
[0040] The reference numerals in the accompanying drawings include: 1. Conditioning tank; 2. Temperature control jacket; 3. pH adjustment assembly; 4. pH detector; 5. Circulation pump; 6. Feed regulating valve; 7. Feed pressure detector; 8. Zoned electric field assisted tangential flow membrane filter; 8. Housing; 81. Feed inlet; 82. Feed outlet; 83. Feed channel; 84. Separation membrane; 85. Separating rib; 86. Permeate chambers 87a-87c; Permeate pressure detectors 88a-88c; Permeate outlets 89a-89c; 810. First electrode; 810. Second electrode. Electrode 811, ion exchange membrane 812, backflushing liquid inlet 813a~813c, permeate branch 9a~9c, product manifold 10, product tank 11, transition liquid return branch 12, product control valve 13a~13c, permeate flow detector 14, transition liquid return valve 15b~15c, reverse pulse storage tank 16, pulse generator 17, backflushing main pipe 18, reverse pulse branch 19, backflushing control valve 20a~20c, discharge branch 21, retentate circulation pipe 22.
[0041] An apparatus for the separation and purification of bioactive peptides, as described in Example 1. Figure 1 and Figure 2The system includes a conditioning component, a feed liquid delivery component, a partitioned membrane separation component, a permeate outlet component, a detection component, a local recovery component, an electric field control component, and a control component. In this embodiment, the conditioning component specifically includes a conditioning tank 1, a temperature control jacket 2, a pH adjustment component 3, and a pH detector 4; the feed liquid delivery component specifically includes a circulating pump 5 and a feed regulating valve 6; the partitioned membrane separation component specifically employs a partitioned electric field-assisted tangential flow membrane filter 8, which forms multiple permeate chambers; the permeate outlet component specifically includes permeate branches 9a-9c connected to different permeate chambers 87a-87c, product control valves 13a-13c, a product manifold 10, and a product tank 11; the detection component specifically includes a feed pressure detector... The system includes a detector 7, a permeate flow detector 14, and permeate pressure detectors 88a-88c; a local recovery assembly specifically includes a reverse pulse reservoir 16, a pulse generator 17, a backflush main pipe 18, a reverse pulse branch 19, and backflush control valves 20a-20c; an electric field control assembly specifically includes multiple electric field control units corresponding to different filtration zones; and a control assembly includes a controller for receiving detection signals and controlling product control valves 13a-13c, backflush control valves 20a-20c, and the electric field operating state, as well as an electric field driver for providing electric field output to each electric field control unit.
[0042] The conditioning component is used for storing and conditioning the bioactive peptide feed solution to be separated. Conditioning tank 1 contains the feed solution obtained after protein hydrolysis. A temperature control jacket 2 is located outside conditioning tank 1, and the temperature of the feed solution inside conditioning tank 1 can be regulated by supplying a heat exchange medium to the temperature control jacket 2, thereby reducing temperature fluctuations during the separation process. A pH detector 4 is used to obtain the pH state of the feed solution inside conditioning tank 1. A pH adjustment component 3 is used to add an acidic, alkaline, or buffer system compatible with the process to conditioning tank 1 to bring the feed solution to a predetermined pH condition. The specific pH conditions are determined based on the isoelectric point of the target bioactive peptide, the net charge state of the target peptide in the feed solution, the surface properties of the separation membrane 85, and the electric field operating mode used, so that the electric field can induce corresponding migration effects on different charged peptide components.
[0043] The outlet of the conditioning tank 1 is connected to the partitioned membrane separation component via a feed delivery assembly. In this embodiment, a circulating pump 5 is installed on the feed pipeline between the conditioning tank 1 and the partitioned membrane separation component to continuously drive the bioactive peptide feed solution into the partitioned membrane separation component; a feed regulating valve 6 is installed on the feed pipeline to regulate the flow rate of the feed solution entering the membrane module. A feed pressure detector 7 is installed near the feed inlet 82 of the membrane module to obtain the pressure of the feed solution entering the membrane module.
[0044] The feed outlet 83 of the partitioned membrane separation unit is connected to the conditioning tank 1 via the retentate circulation pipe 22, allowing proteins, macropeptides, or other retentate components that have not permeated through the separation membrane 85 to return to the conditioning tank 1 for continued circulation. A back pressure regulating structure can also be installed on the feed outlet 83 side. This back pressure regulating structure works in conjunction with the circulation pump 5 to create a transmembrane pressure suitable for membrane separation between the feed side and the permeate side of the separation membrane 85. A discharge branch 21 is provided on the retentate circulation pipe 22. When the circulating feed reaches a predetermined concentration or when retentate components need to be discharged, the corresponding feed can be discharged from the system via the discharge branch 21.
[0045] like Figure 2 As shown, the partitioned membrane separation assembly includes a housing 81, with a feed inlet 82 at one end and a feed outlet 83 at the other end. A continuous tangential feed channel 84 extends from the feed inlet 82 to the feed outlet 83 within the housing 81. A separation membrane 85 is disposed on one side of the continuous tangential feed channel 84, with its membrane surface positioned along the extending direction of the channel, allowing the bioactive peptide feed entering the membrane assembly to flow along the membrane surface of the separation membrane 85.
[0046] In this embodiment, the continuous tangential flow feed channel 84 refers to a feed channel where the feed sides of each filtration zone are interconnected. The feed does not need to pass through a physical separation structure that isolates the feed sides of different filtration zones during its flow from the upstream filtration zone to the downstream filtration zone. Therefore, although the separation membrane 85 is divided into multiple filtration zones with different control states, each filtration zone still corresponds to the same continuous feed flow path.
[0047] A partition rib 86, serving as a partition structure, is provided on the side of the separation membrane 85 facing away from the continuous tangential flow channel 84. In this embodiment, the partition structure is specifically the partition rib 86; in other embodiments, other partition structures capable of achieving the same partitioning function can be used as long as multiple liquid-tightly separated permeable regions can be formed on the permeable side of the separation membrane 85. The partition rib 86 forms a liquid-tight fit with the permeable side of the separation membrane 85 and the housing 81, dividing the permeable side of the separation membrane 85 sequentially into a first permeable liquid cavity 87a, a second permeable liquid cavity 87b, and a third permeable liquid cavity 87c along the flow direction of the liquid. The three permeable liquid cavities 87a to 87c are not directly connected to each other.
[0048] Thus, the section of separation membrane 85 corresponding to the first permeate chamber 87a forms the first filtration zone A, the section of separation membrane 85 corresponding to the second permeate chamber 87b forms the second filtration zone B, and the section of separation membrane 85 corresponding to the third permeate chamber 87c forms the third filtration zone C. The permeate sides of the three filtration zones are independent of each other, but the feed liquid sides of the three filtration zones remain continuous. After the feed liquid enters the continuous tangential flow feed liquid channel 84, it flows sequentially along the membrane surfaces corresponding to the first filtration zone A, the second filtration zone B, and the third filtration zone C.
[0049] The above-described three-filtration zone structure is only used to illustrate the operation of this embodiment and does not imply that the number of zones must be three. For devices with different membrane areas and processing capacities, two filtration zones or more than four filtration zones can be set. Each filtration zone is configured with independent permeate chambers 87a-87c, independent outlet paths, and independent local recovery paths.
[0050] The permeate outlet assembly is connected to each permeate chamber 87a-87c. Each permeate chamber 87a-87c is provided with a permeate outlet 89a-89c, and each permeate outlet 89a-89c is connected to a corresponding permeate branch 9a-9c. Each permeate branch 9a-9c further flows into the product manifold 10, which is connected to the product tank 11. Each permeate branch 9a-9c is provided with a product control component. In this embodiment, the product control component is specifically a product control valve 13a-13c. Different product control valves 13a-13c can be opened or closed independently, thereby allowing for individual determination of whether the permeate generated in a certain filtration zone enters the product manifold 10 without simultaneously changing the product collection state of other filtration zones.
[0051] Each filtration zone is also equipped with a detection component. A permeate flow rate detector 14 is installed in each permeate branch 9a-9c to obtain the permeate volume generated per unit time in the corresponding filtration zone; a permeate pressure detector 88a-88c can also be installed in each permeate chamber 87a-87c or the corresponding permeate branch 9a-9c to obtain the pressure status on the permeate side of the corresponding filtration zone. Combined with the feed-side pressure, the transmembrane pressure corresponding to the filtration zone can also be determined or estimated.
[0052] When further improvement in the accuracy of local filtration status determination is required, multiple feed-side pressure detection positions corresponding to different filtration zones can be set along the continuous tangential feed channel 84, enabling the controller to obtain the corresponding transmembrane pressure based on the feed-side pressure and permeate-side pressure of each filtration zone. This local pressure detection method, as a further implementation of the detection component, does not change the basic structure of permeate-side partitioning and local recovery.
[0053] The controller can convert the corresponding permeate flow rate into permeate flux based on the effective membrane area of each filtration zone, and compare the current permeate flux with the initial stable permeate flux obtained by that filtration zone under normal filtration conditions. It can also incorporate changes in transmembrane pressure, using the degree of decrease in permeate flow rate, the degree of decrease in permeate flux, changes in transmembrane pressure, or the permeate capacity per unit transmembrane pressure as membrane condition judgment parameters. When one filtration zone reaches a preset membrane recovery condition, while at least one of the remaining filtration zones remains within the normal filtration range, the controller executes a partial recovery procedure on the filtration zone that has reached the recovery condition.
[0054] The local recovery component is used to apply a hydraulic force opposite to the normal filtration direction from the permeate side of the separation membrane 85 to the feed liquid side. The reverse pulse reservoir 16 is used to store the reverse pulse medium. The reverse pulse reservoir 16 is connected to the backflush main pipe 18 through the pulse generator 17. The backflush main pipe 18 is connected to the backflush liquid inlets 813a-813c corresponding to different permeate liquid chambers 87a-87c through multiple reverse pulse branches 19. Each reverse pulse branch 19 is equipped with a backflush control component. In this embodiment, the backflush control component is specifically a backflush control valve 20a-20c.
[0055] By controlling different backwash control valves 20a to 20c respectively, the reverse pressure pulse generated by the pulse generator 17 can be made to enter only the selected permeate chambers 87a to 87c, while the other permeate chambers 87a to 87c remain in normal filtration state. After the reverse pressure pulse enters the corresponding permeate chamber 87a to 87c, the liquid in that permeate chamber 87a to 87c passes through the separation membrane 85 from the permeate side to the direction of the continuous tangential flow of the feed liquid channel 84. Its transmembrane flow direction is opposite to the flow direction from the feed liquid side to the permeate side during normal filtration.
[0056] The reverse pulse reservoir 16 preferably stores clean permeate obtained from the separation process, ensuring good process compatibility between the reverse pulse medium and the current product system. Alternatively, purified water, buffer solution, or other process-compatible liquids can be used as the reverse pulse medium, depending on the properties of the target peptide, the properties of the separation membrane 85, and the requirements of subsequent products. The pulse generator 17 can employ a pressure generating structure capable of rapidly increasing the permeate-side pressure and creating reverse transmembrane flow.
[0057] In this embodiment, the transmembrane pressure during normal filtration can be set in the range of 0.05 MPa to 0.30 MPa, and the tangential flow velocity of the feed liquid along the membrane surface of the separation membrane 85 can be set in the range of 0.2 m / s to 2.0 m / s. During partial membrane recovery, the duration of a single reverse pressure pulse can be set to 0.2 s to 3 s, and one or more reverse pulses can be executed depending on the degree of fouling. The specific value of the reverse pressure is determined based on the reverse pressure that the separation membrane 85 can withstand, ensuring that the reverse pressure is sufficient to generate a short-term reverse flow from the permeate side to the feed liquid side, while not exceeding the mechanical load allowed by the membrane module.
[0058] The electric field control assembly includes multiple electric field control units corresponding to the filtration zones. In this embodiment, each electric field control unit includes a first electrode 810 and a second electrode 811 located on both sides of the corresponding filtration zone. The first electrode 810 is located on one side of the continuous tangential flow channel 84, and the second electrode 811 is located on the corresponding permeation side, so that the first electrode 810 and the second electrode 811 can form an electric field action area across the separation membrane 85 of the corresponding filtration zone.
[0059] To reduce the direct impact of electrode reactions on the bioactive peptide process feed solution, a first electrode 810 can be disposed in a first electrode 810 cavity, with an ion exchange membrane 812 disposed between the first electrode 810 cavity and the continuous tangential flow feed solution channel 84; a second electrode 811 can be disposed in a second electrode 811 cavity, with an ion exchange membrane 812 disposed between the second electrode 811 cavity and the corresponding permeation side. The electrode cavity can be connected to the electrode solution circulation assembly to maintain the electrode solution environment required for electrode operation, while the electrode solution and the bioactive peptide process feed solution are separated by the ion exchange membrane 812.
[0060] The electrode action areas corresponding to different filtration zones are respectively set along the direction of liquid flow. The first electrode cavity 810 and the second electrode cavity 811 can form multiple electrode partitions corresponding to different filtration zones through an insulating separation structure, so that the electric fields between different filtration zones can be controlled independently. Each electric field control unit is connected to an electric field driver, and the electric field driver adjusts the electric field operating state of each electric field control unit under the control of the controller.
[0061] Under normal separation conditions, each electric field control unit can apply a DC electric field, a pulsed DC electric field, or a periodically varying electric field according to the net charge state of the target bioactive peptide under the current pH conditions. This allows the electric field effect and the sieving effect of the separation membrane 85 to jointly influence the migration of peptide components. When a local recovery is performed in a certain filtration zone, the electric field control unit corresponding to that filtration zone enters the membrane recovery electric field state. The membrane recovery electric field state can be achieved by one or more of the following methods: turning off the normal separation electric field, changing the electric field strength, changing the electric field polarity, applying an alternating electric field, or applying a pulsed electric field. Meanwhile, the filtration zones that have not undergone recovery still maintain the electric field state required for normal separation.
[0062] This invention does not require a specific electric field strength or potential difference as a necessary condition for achieving local recovery. The key point is that each filter zone has an independent electric field adjustment capability, and when one of the filter zones enters a local recovery state, the electric field state corresponding to that filter zone is different from at least one filter zone that is still in a normal separation state.
[0063] When the present invention is used normally, the bioactive peptide solution to be separated is first added to the conditioning tank 1, the temperature of the solution is adjusted by the temperature control jacket 2, and the pH of the solution is adjusted to a pH state that is compatible with the separation process of the target peptide by the pH detector 4 and the pH adjustment component 3.
[0064] After the circulation pump 5 starts, the feed liquid in the conditioning tank 1 enters the partitioned membrane separation component through the feed regulating valve 6. Under the action of the circulation pump 5 and the back pressure on the side of the feed liquid outlet 83, the feed liquid flows through the membrane surface of the separation membrane 85 corresponding to different filtration zones in sequence along the continuous tangential flow feed liquid channel 84, and transmembrane pressure is formed on both sides of the separation membrane 85.
[0065] Peptide and liquid components that meet the separation conditions pass through the separation membrane 85 under the action of transmembrane pressure and corresponding electric field, and enter their respective permeate chambers 87a-87c. They then flow into the product manifold 10 and into the product tank 11 through the permeate branches 9a-9c. Components that do not pass through the separation membrane 85 flow out from the feed outlet 83 and return to the conditioning tank 1 through the retentate circulation pipe 22 for continued circulation.
[0066] The following example, taking the second filtration zone B as an example of achieving membrane recovery conditions, illustrates the local recovery process.
[0067] During normal filtration, the product control valves 13a-13c of all three filtration zones are open, while the backwash control valves 20a-20c are closed. When the parameters obtained by the detection component indicate that the second filtration zone B has reached the preset membrane recovery condition, while the first filtration zone A and the third filtration zone C are still within the normal operating range, the controller first closes the product control valve 13b corresponding to the second filtration zone B, temporarily isolating the second permeate chamber 87b from the product manifold 10.
[0068] At this point, the first filtration zone A continues normal tangential flow filtration and product collection. The third filtration zone C can continue normal filtration and product collection; when it is necessary to reduce the short-term impact of substances shed during the recovery process of the second filtration zone B on downstream products, the destination of the permeate generated in the third filtration zone C can also be temporarily changed.
[0069] Subsequently, the controller opens the backflush control valve 20b corresponding to the second filtration zone B. The pulse generator 17 sends the reverse pulse medium into the second permeate chamber 87b through the backflush main pipe 18 and the corresponding reverse pulse branch 19, causing the second permeate chamber 87b to generate a reverse pressure pulse. The reverse pulse medium passes through the second permeate chamber 87b, through the separation membrane 85 corresponding to the second filtration zone B, and enters the continuous tangential flow liquid channel 84, generating a hydrodynamic force on the membrane surface of the filtration zone that is opposite to the normal filtration direction.
[0070] During the reverse pulse process in the second filtration zone B, the continuous tangential flow liquid channel 84 does not stop supplying liquid. Therefore, reversible deposits, adsorbents, or fouling layers that detach from the membrane surface of the second filtration zone B can enter the continuous liquid flow and leave the second filtration zone B under the action of tangential flow.
[0071] Simultaneously, before, or after the aforementioned reverse pulse, the controller switches the electric field control unit corresponding to the second filtration zone B from the normal separation electric field state to the membrane restoration electric field state, so that the change in electric field state and the reverse liquid flow act together on the second filtration zone B. The electric field control units corresponding to the first filtration zone A and other filtration zones that maintain normal filtration remain in the normal separation state.
[0072] After one or more reverse pulses are completed in the second filtration zone B, the controller closes the corresponding backflush control valves 20a to 20c, restoring the corresponding electric field control unit to its normal separation electric field state and re-establishing normal transmembrane filtration conditions in the second filtration zone B. The detection component then obtains the permeate flow rate and / or pressure parameters of the second filtration zone B again.
[0073] When the filtration status of the second filtration zone B returns to the preset restart conditions, the controller reopens the product control valve 13b corresponding to the second filtration zone B, allowing the permeate produced to re-enter the product manifold 10. If the restart conditions are not met after one partial recovery, the reverse pulse and electric field recovery process can be repeated. If the system still cannot return to normal operating range after a preset number of recovery cycles, a prompt can be made to perform a complete cleaning of the membrane module or replace the separation membrane 85.
[0074] Example 2 is an implementation method for setting up a transition fluid guiding component.
[0075] Based on the above embodiments, at least the permeate branches 9a to 9c located downstream of other filtration zones can be connected to the transition liquid return branch 12. In this embodiment, the permeate branches 9b to 9c corresponding to the second filtration zone B and the third filtration zone C can be connected to the transition liquid return branch 12 through the transition liquid return valves 15b to 15c, respectively. The transition liquid return branch 12 can be connected to the conditioning tank 1, or it can be connected to an independent transition liquid collection container or a reprocessing unit.
[0076] Taking the partial recovery of the second filtration zone B as an example, after the second filtration zone B undergoes a reverse pulse, the material detached from its membrane surface moves towards the third filtration zone C under the action of continuous tangential flow. At this time, the third filtration zone C can continue to filter, but its flow path into the normal product confluence path is closed, and the permeate generated in the third filtration zone C is temporarily introduced into the transition liquid return branch 12.
[0077] After the second filtration zone B has partially recovered, and the liquid affected by the partial recovery in the continuous tangential flow liquid channel 84 has undergone a preset replacement or stabilization process, the transition liquid return path corresponding to the third filtration zone C is then closed and its normal product collection path is restored. Thus, without completely stopping filtration in the third filtration zone C, the extent to which transient liquid enters the normal product collection flow path during the partial recovery process can be reduced.
[0078] When the first filtration zone A is partially restored, the permeate from the downstream second filtration zone B and / or the third filtration zone C can be temporarily introduced into the transition liquid return path according to process requirements. When the third filtration zone C is partially restored, since it is located downstream of the feed liquid flow direction, it can be determined whether additional transition liquid switching is required based on the actual operating status of the system.
[0079] Partitioned membrane separation modules are not limited to forming three filtration zones. For membrane modules with a smaller processing area, the permeate side of the separation membrane can be divided into two independent permeate chambers; for membrane modules with a larger membrane area, more partitioning structures can be set along the feed flow direction to divide the permeate side into four, five, six or more filtration zones.
[0080] Each filtration zone is still equipped with an independent permeate outlet path, an independent reverse pulse path, and a corresponding electric field control unit, so that increasing the number of filtration zones does not change the basic working principle of the present invention: "continuous feed liquid side, partitioned permeate side, and local independent recovery".
[0081] Example 3 is an implementation method with multiple filtration zones and multi-stage membrane separation, such as... Figure 3 As shown. Multiple partitioned membrane separation modules can also form a multi-stage bioactive peptide separation system by connecting them in series, parallel, or series-parallel. In the series structure, the feed liquid side outlet of the previous partitioned membrane separation module can be connected to the feed liquid side inlet of the next partitioned membrane separation module. Each stage of the membrane module can use separation membranes 85 with different retention characteristics, so that different stages of the membrane module can respectively perform the corresponding functions in the retention of large molecular proteins and peptides, target peptide fractionation, target component concentration, or desalting treatment.
[0082] Each level of the membrane separation module can perform filtration status detection and partial recovery for its different filtration zones in the manner described above. Therefore, when one filtration zone of a primary membrane module reaches the recovery condition, it is not necessary to cause all filtration zones of that level and the entire multi-stage separation system to stop working simultaneously.
[0083] The separation membrane 85 used in this device can be selected from ultrafiltration membranes, compact ultrafiltration membranes, nanofiltration membranes, or other selective membranes suitable for the separation of bioactive peptides, depending on the molecular weight distribution of the bioactive peptides to be separated, the characteristics of the target components, and the process requirements. Figure 2 The flat panel structure shown can also be replaced by other membrane module structures that can maintain a continuous feed side and form multiple independent permeation zones.
[0084] The conditioning tank 1, membrane module housing 81, piping, and valves that come into contact with the bioactive peptide feed solution are made of materials selected according to the hygiene and corrosion resistance requirements of the food, biopharmaceutical, or related production fields. The partitioned membrane separation module can also adopt a detachable clamping structure, allowing the separation membrane 85, the partition structure, and the corresponding components forming the feed solution channel 84 to be disassembled, cleaned, or replaced.
[0085] Example 4 discloses a method for the separation and purification of bioactive peptides, implemented using the separation and purification apparatus described in any of the preceding examples. Alternatively, it can be implemented using other apparatuses with a continuous tangential flow feed channel 84, independent permeate sides in different zones, a local reverse recovery structure, and independent electric field control functions in different zones. The method mainly includes feed conditioning, continuous tangential flow filtration, zoned state detection, local membrane recovery, and a re-injection process after recovery.
[0086] First, the bioactive peptide solution to be separated and purified is placed in a conditioning container, and the state of the solution is adjusted according to the stability, charge properties of the target bioactive peptide, and the performance of the separation membrane 85 used. The solution can be a peptide-containing mixture obtained after enzymatic hydrolysis, fermentation, or other degradation treatments of proteins. The pH of the solution is adjusted according to the isoelectric point and net charge state of the target peptide, and the temperature is controlled according to the stability of the peptides, so that the solution is in a state suitable for subsequent membrane separation and electric field-assisted migration.
[0087] After the feed solution is prepared, the bioactive peptide feed solution is driven into the membrane separation unit, causing the feed solution to form a continuous tangential flow along the feed side of the separation membrane 85. The permeate side of the separation membrane 85 is divided into at least two independent permeate regions along the feed flow direction, each permeate region corresponding to a different membrane surface region of the separation membrane 85, thereby forming at least two filtration zones. The feed sides of each filtration zone are interconnected, allowing the feed solution to pass through different filtration zones sequentially along the same continuous tangential flow path, while the permeate sides of each filtration zone are independent of each other.
[0088] During the normal separation phase, transmembrane pressure is established across the separation membrane 85 by adjusting the feed liquid delivery state and the pressure on the feed liquid outlet 83 side. Simultaneously, electric fields are applied to different filtration zones to assist peptide component migration. As the bioactive peptide feed liquid continuously flows along the membrane surface of the separation membrane 85, liquid components and peptide components meeting the corresponding separation conditions pass through the separation membrane 85 under the combined action of the transmembrane pressure and the electric field of the corresponding filtration zone, entering their respective permeate regions and being discharged through the permeate output paths of each filtration zone. Components that do not permeate the separation membrane 85 continue to flow in the continuous tangential flow direction and are either recycled or discharged according to process requirements.
[0089] In one specific operating mode, the transmembrane pressure during the normal filtration stage can be set to 0.05 MPa to 0.30 MPa, and the tangential flow velocity of the feed solution along the membrane surface of separation membrane 85 can be set to 0.2 m / s to 2.0 m / s. The above parameters are only an example of how this method can be implemented; the actual operating parameters can be adjusted according to the type of separation membrane 85, the properties of the target peptide, and the concentration and viscosity of the feed solution.
[0090] During the continuous separation process, the filtration status of different filtration zones is obtained. The filtration status can be determined based on one or more parameters among the permeate flow rate, permeate flux per unit membrane area, permeate side pressure, and corresponding transmembrane pressure of each filtration zone.
[0091] For example, the permeate flux of a filter zone after reaching a stable state during the initial stage of normal operation can be recorded, and the actual permeate flux during subsequent operation can be compared with this initial stable permeate flux. When the actual permeate flux drops to a preset percentage, the filter zone is determined to have reached a preset recovery condition. In addition to the above determination method, whether the filter zone has reached the recovery condition can also be determined based on the permeate flow rate decrease rate, the degree of permeate flux decrease, the transmembrane pressure change rate, the permeate capacity corresponding to unit transmembrane pressure, or a combination of two or more of these parameters.
[0092] Because different filtration zones are located at different points along the feed flow direction, the feed concentration, pressure, flow state, and contaminant accumulation at their respective locations may vary. Therefore, each filtration zone can reach recovery conditions at different times. This method does not require all filtration zones to stop operating simultaneously when one filtration zone reaches recovery conditions; instead, it performs localized recovery on the filtration zones that have reached recovery conditions.
[0093] The following example illustrates the situation where the second filter zone in a multi-filter system reaches the recovery condition, while at least one of the remaining filter zones remains in a normal filtration state.
[0094] When the second filtration zone is detected to have reached the preset recovery condition, the normal product output of that filtration zone is first stopped, isolating its permeate side from the normal product collection flow path. Simultaneously, at least one filtration zone that has not reached the recovery condition continues tangential flow filtration. The continuous tangential flow on the feed side remains uninterrupted, ensuring the feed continues to flow continuously from upstream to downstream along the membrane surface of separation membrane 85.
[0095] Subsequently, reverse pressure is applied from the permeate side of the second filtration zone that has reached the recovery condition to the feed liquid side, causing the reverse recovery liquid to pass through the separation membrane 85 from the permeate side of the filtration zone and enter the continuous tangential feed liquid side, thereby forming a reverse liquid flow in the filtration zone that is opposite to the normal filtration transmembrane flow direction.
[0096] The reverse recovery solution can be a clean permeate obtained during the separation process, or it can be purified water, buffer solution, or other liquids compatible with the bioactive peptide separation process. Using a clean permeate reduces the possibility of the added recovery solution affecting the current product system.
[0097] The reverse flow is preferably applied in the form of pressure pulses. A single reverse pressure pulse can last from 0.2 to 3 seconds and can be applied once or multiple times at intervals, depending on the degree of fouling in the filtration zone. The magnitude of the reverse pressure is determined based on the reverse pressure that the separation membrane 85 can withstand, so that it can form a liquid flow from the permeate side to the feed side, while avoiding exceeding the mechanical load allowed by the separation membrane 85 and the membrane module.
[0098] When the reverse flow passes through the separation membrane 85, a hydrodynamic force opposite to the normal filtration direction is applied to the reversible deposit layer adsorbed on or formed on the membrane surface, causing at least some of the contaminants to detach from the membrane surface. Since the continuous tangential feed liquid continues to flow along the membrane surface during the reverse recovery process, the substances detached from the membrane surface of the filtration zone to be recovered can enter the main feed stream and leave the filtration zone with the tangential flow, thus preventing the detached substances from remaining in the original contaminated area.
[0099] While, before, or after applying the reverse liquid flow, the electric field state corresponding to the filtration zone that has reached the recovery condition is also changed, so that the electric field state of the filtration zone is different from that of at least one filtration zone that still maintains a normal filtration state.
[0100] Specifically, during normal filtration, each filtration zone can be subjected to a DC electric field, a pulsed DC electric field, or a periodically varying electric field. The direction of the electric field is selected based on the net charge properties of the target peptide under the current pH conditions and the surface properties of the separation membrane 85. When the second filtration zone enters a local recovery state, the original normal separation electric field of that filtration zone can be turned off, or its electric field strength, polarity, alternating electric field, or pulsed electric field can be applied. The above-mentioned electric field changes can be used individually or according to the composition of the fouling layer and the combination of membrane materials.
[0101] When the aforementioned electric field state change is performed in the second filtration zone, at least one of the remaining filtration zones, which is still in a normal filtration state, continues to maintain an electric field state adapted to normal peptide separation. Thus, the reverse hydrodynamic force and the electric field effect distinct from the normal filtration state are concentrated on the local filtration zone requiring recovery, without requiring the entire membrane module to simultaneously undergo reverse recovery or a uniform change in the electric field state.
[0102] When the filtration zone undergoing partial recovery is not the downstream filtration zone in the feed flow direction, some substances detached from its membrane surface may flow downstream with the continuous tangential feed flow. To reduce the impact of the transient feed during the partial recovery phase on product collection in the downstream filtration zone, at least one filtration zone downstream of the zone to be recovered can continue filtration, but the flow direction of the permeate generated in that downstream filtration zone can be temporarily changed so that the permeate does not temporarily enter the normal product collection flow path.
[0103] The permeate generated in the downstream filtration zone can be temporarily returned to the feed conditioning zone, or it can enter a separate transition liquid collection zone or a reprocessing zone. After the local recovery is completed, the feed liquid continues to run along the continuous tangential feed liquid channel 84 for a preset stabilization time or undergoes a corresponding replacement process. After the transient feed liquid affected by the local recovery leaves the corresponding downstream area, the normal product output of the downstream filtration zone is restored.
[0104] After one or more reverse flow actions and corresponding electric field changes, the reverse pressure applied to the filtration zone to be restored is stopped, and its corresponding electric field is restored to the normal separation electric field state. Subsequently, the normal transmembrane filtration conditions are re-established in the filtration zone, and the permeate flow rate, permeate flux, and / or pressure state of the filtration zone are obtained again.
[0105] When the filtration status obtained from the re-detection meets the preset re-injection conditions, the normal product output of the filtration zone is restored, and the permeate produced by it re-enters the product collection flow path.
[0106] If the conditions for restarting are not met after a partial recovery, the reverse flow and electric field state adjustment process can be performed again on the filtration zone. After a preset number of partial recoveries, if the corresponding filtration zone still cannot return to normal operating range, the product output of the filtration zone can be stopped, and the membrane module can be further cleaned, maintained, or the separation membrane 85 can be replaced.
[0107] The above description of partial recovery using the second filtration zone is only for illustrating the operation of this method. When the first filtration zone, the third filtration zone, or any other filtration zone reaches the recovery condition, the product output of the corresponding filtration zone can be stopped in the same manner, a reverse liquid flow can be applied from the corresponding permeation side, and the electric field state of the corresponding filtration zone can be changed, while at least one of the remaining filtration zones that has not reached the recovery condition continues to filter.
[0108] Using the above method, the bioactive peptide feed solution can maintain continuous tangential flow along the feed solution side of the separation membrane 85 throughout the entire local recovery process. Each filtration zone enters either normal filtration or local recovery state according to its actual filtration status, thus eliminating the need for the entire membrane module to simultaneously stop filtration to recover from local membrane fouling. Simultaneously, by applying reverse flow and changes in the electric field to the filtration zone requiring recovery, and utilizing the continuous tangential feed flow to remove contaminants detached from the membrane surface, coordinated operation between zoned membrane recovery and continuous bioactive peptide separation can be achieved.
[0109] The above description is merely a preferred embodiment of the present invention and is not intended to limit the present invention in any way. Although the present invention has been disclosed above with reference to preferred embodiments, it is not intended to limit the present invention. Any person skilled in the art can make some modifications or alterations to the above-disclosed technical content to create equivalent embodiments without departing from the scope of the present invention. Any indirect modifications, equivalent changes, and alterations made to the above embodiments based on the technical essence of the present invention without departing from the scope of the present invention shall still fall within the scope of the present invention.
Claims
1. A device for separating and purifying bioactive peptides, comprising a membrane separation component, a permeate extraction component, a local recovery component, and an electric field modulation component, characterized in that: The membrane separation assembly has a continuous tangential feed channel and a separation membrane disposed on one side thereon. The permeation side of the separation membrane is divided into at least two independent permeation chambers along the feed flow direction, and each of the permeation chambers forms a filtration zone. The permeate discharge assembly is used to control the permeate output of each of the permeate chambers respectively; The local recovery component is used to selectively generate a reverse flow of liquid from the permeation side to the feed liquid side in any of the filter zones; Each of the filter zones is provided with an independently adjustable electric field control unit so that when one filter zone undergoes partial recovery, at least one of the remaining filter zones maintains the filtering state.
2. The apparatus for separating and purifying bioactive peptides according to claim 1, characterized in that: The membrane separation assembly includes a housing, which has a feed inlet and a feed outlet, and the continuous tangential flow feed channel extends from the feed inlet to the feed outlet; The permeation side of the separation membrane is provided with a partition structure, which forms a liquid-tight connection with the separation membrane and the housing, so that adjacent permeation liquid chambers are not directly connected to each other, and the feed liquid side of each filtration zone is connected to the continuous tangential flow feed liquid channel.
3. The apparatus for separating and purifying bioactive peptides according to claim 1, characterized in that: The permeate discharge assembly includes a permeate branch that is connected to each of the permeate chambers and a product manifold that is connected to each of the permeate branches. Each of the permeate branches is provided with a product control valve to independently control the connection state between the corresponding permeate chamber and the product manifold.
4. The apparatus for separating and purifying bioactive peptides according to claim 1, characterized in that: The local recovery assembly includes a reverse pulse reservoir, a pulse generator, a backflush main pipe, and reverse pulse branches that are respectively connected to each of the permeable liquid chambers. The reverse pulse reservoir is connected to the backflush main pipe through the pulse generator, and each of the reverse pulse branches is provided with a backflush control valve. The pulse generator is used to apply a reverse pressure pulse to a selected permeate chamber, causing the reverse pulse medium to pass through the separation membrane of the corresponding filtration zone and enter the continuous tangential flow liquid channel.
5. The apparatus for separating and purifying bioactive peptides according to claim 1, characterized in that: Each of the electric field control units includes a first electrode and a second electrode located on both sides of the corresponding filtration zone. An ion exchange membrane is provided between the first electrode and the continuous tangential flow liquid channel and between the second electrode and the corresponding permeation side. The electric field control units corresponding to different filter zones are connected to the electric field driver to independently perform at least one of the following: electric field opening, closing, field intensity adjustment, polarity change, pulse adjustment, or alternating adjustment.
6. The apparatus for separating and purifying bioactive peptides according to claim 1, characterized in that: It also includes a detection component and a control component, wherein the detection component is used to acquire at least one of the permeate flow rate and permeate side pressure in each of the filtration zones; The control component is used to determine the filtration status of each filtration zone according to the filtration status parameters, and to control the permeate output, reverse flow and electric field operation status of the corresponding filtration zone, so that the filtration zone that has reached the preset recovery condition can perform local recovery.
7. The apparatus for separating and purifying bioactive peptides according to claim 1, characterized in that: It also includes a conditioning tank for containing bioactive peptide solution and a circulation pump for driving the solution into the continuous tangential flow solution channel, wherein the conditioning tank is equipped with a temperature control component and a pH control component. The feed outlet of the membrane separation unit is connected to the conditioning tank via a retentate circulation pipe, so that the feed that has not passed through the separation membrane is returned to the conditioning tank for recycling.
8. The apparatus for separating and purifying bioactive peptides according to claim 1, characterized in that: The permeate output path of at least one of the filter zones is also connected to the transition liquid guide branch so that when a filter zone is partially restored, the permeate generated by at least one filter zone downstream of that filter zone can temporarily leave the product collection flow path. And / or, the membrane separation assembly is configured as two or more, and each membrane separation assembly is connected in series, parallel or series-parallel, and at least two of the membrane separation assemblies use separation membranes with different retention characteristics.
9. A method for the isolation and purification of bioactive peptides, characterized in that: The bioactive peptide feed solution is continuously tangentially flowed along the feed side of the separation membrane, and the permeate of the corresponding filtration zone is collected by at least two independent permeate chambers located on the permeate side of the separation membrane. The filtration state of each filtration zone is determined. When a filtration zone reaches the recovery condition, the product output of that filtration zone is stopped, a reverse liquid flow is applied from its permeation side to the liquid side, and the electric field state corresponding to that filtration zone is changed, while at least one other filtration zone is kept filtering. After the recovery is complete, the filtration area will resume product output.
10. The method for isolating and purifying bioactive peptides according to claim 9, characterized in that: Whether the filtration zone has reached the recovery condition is determined based on at least one of the following: permeate flow rate, permeate flux, transmembrane pressure, permeate flow rate decrease rate, permeate flux decrease degree, transmembrane pressure change rate, and permeate capacity corresponding to unit transmembrane pressure. During the local recovery process, one or more reverse pressure pulses are applied to the filter zone that has reached the recovery condition, and the electric field corresponding to the filter zone is subjected to at least one of the following: shutdown, field strength change, polarity change, alternating change, or pulse change. When there is a filtration zone that maintains filtration status downstream of the filtration zone undergoing partial restoration, the permeate generated by at least one of the downstream filtration zones is temporarily introduced into the transition liquid return path or the transition liquid collection path, and the product output of the downstream filtration zone is restored after the partial restoration is completed and the liquid status is stable.
